Seroprevalence, incomplete data in the wake of the Omicron wave

Almost 60% of Americans had antibodies from a prior COVID-19 case in February 2022, a CDC study found. This rate was even higher among young children and teenagers.

More than half of Americans have some antibodies from a recent coronavirus infection, according to a new CDC report. The study was published Tuesday in the CDC’s Morbidity and Mortality Weekly Report (MMWR), accompanied by a press conference and other fanfare. To me, this report (and its publicity) reflects the CDC’s current lack of urgency around addressing the pandemic and its continued impacts.

The CDC regularly surveys COVID-19 antibody levels among the U.S. population, a metric that scientists call seroprevalence. For these surveys, the agency works with commercial laboratories to measure antibody rates from a nationally representative sample of Americans, with updates provided about once a month. The survey specifically looks at a type of antibody that develops in response to infection, not vaccination.

This most recent iteration of the survey, providing data from February 2022, is particularly notable: the CDC estimates that 58% of Americans had this immune system indicator of a recent COVID-19 infection, immediately after the nation’s massive Omicron wave. Not all of these people got COVID-19 during the Omicron wave, though, since some of these antibodies stem from earlier infections.

Other notable findings include:

  • National seroprevalence increased from 34% in December 2021 to 58% in February 2022—the largest jump recorded in this survey—reflecting the Omicron wave’s impact.
  • Children and teenagers had the highest antibody levels. For the 12 to 17 age group, seroprevalence went from 46% in December 2021 to 74% in February 2022.

There are some major caveats to this study, though, including:

  • The imprecise nature of this antibody measurement. The type of antibody measured in this seroprevalence survey “stays positive for at least two years after infection,” CDC scientist Dr. Kristie Clarke said on the agency’s press call.
  • Antibodies wane at different rates and levels for different people, so it’s unclear to what extent this 58% finding actually reflects the share of Americans who have gotten COVID-19 since spring 2020.
  • Plus, some people infected by the coronavirus never seroconvert, meaning that they don’t develop antibodies at all (and thus wouldn’t show up in this study).
  • While we know that the COVID-19 antibodies identified in this study confer some protection against new infections, it’s unclear how long that protection lasts or how it might hold up against new variants.

To me, this study (and the CDC’s choice to promote it with one of the agency’s infrequent press calls) exemplifies the Biden administration’s COVID-19 response right now.

As I listened to the press call, the CDC’s interpretation of this study was clear: more than half of Americans have some protection against COVID-19 from a prior infection, and many of those people also have protection against vaccination. Much of that protection applies specifically to Omicron and will likely help us avoid a crisis from BA.2, so it gives the U.S. additional reason to relax safety measures, the CDC suggested.

(Worth noting: the CDC still recommends vaccination and booster shots for anyone who had a previous coronavirus infection, including children. But that message is not getting across right now, as evidenced by our low booster shot uptake.)

When you ask for more specifics on that “protection” from prior infections, though, the CDC isn’t able to provide much information. Again, we don’t know how long the protection lasts or how it holds up against other variants. And we have no idea how many people had mild or asymptomatic COVID-19 cases, then did not seroconvert.

The CDC’s press call also failed to mention Long COVID, which is a risk from any COVID-19 case—no matter how mild. Some Long COVID researchers have also suggested that lack of seroconversion, or even a prior infection in general, may increase a patient’s future risk for prolonged symptoms the next time they get infected.

And, of course, the CDC report also exemplifies our current lack of surveillance. How many of those Omicron infections between December and February were actually caught by PCR testing and reported to the CDC? A small fraction. At the press call. Dr. Clarke mentioned an upcoming CDC study that estimates how many infections go uncounted for every one reported case:

In the Omicron period, we found that over that time period, the infection to case ratio was the highest that it’s been, at over three estimated infections per reported case. And that varied by region, so depending on which US census region the estimates were, you know, the ratios were higher or lower.

Surely that ratio is getting even higher now. To me, this forthcoming study, combined with the seroprevalence report, is a reminder that the cases we see in our datasets and dashboards are a very incomplete picture of actual coronavirus transmission in the U.S. And yet the CDC is using this incomplete picture to suggest we all relax, take our masks off, and forget about the pandemic.

Sign up for the COVID Data Dispatch newsletter

More federal data

Orders of free at-home COVID-19 tests varied widely by state
On September 2, 2022, the federal government stopped taking orders for free at-home COVID-19 tests. The day this program ended, I sent a public records request to the federal government asking for data on how many tests were distributed. I …
12 statistics showing the pandemic isn’t over
Last Sunday, 60 Minutes aired an interview with President Joe Biden in which he declared the pandemic is “over," noting that everyone at the Detroit Auto Show "seems to be in pretty good shape." But there are millions of Americans …
Potential data fragmentation when the federal COVID-19 public health emergency ends
COVID-19 is still a public health emergency. At the moment, this is true according to both the general definition of this term and official declarations by the federal government. But the latter could change in the coming months, likely leading …
Tips for interpreting COVID-19 data while the CDD goes on hiatus
The COVID-19 Data Dispatch is going on hiatus for the month of August 2022. Here are some tips for keeping track of COVID-19 numbers while we're on this break, and a bit of context about why we're taking four weeks …
CDC stops sharing cruise ship COVID-19 data
As of last Monday, the CDC is no longer reporting data about COVID-19 outbreaks on cruise ships. This change comes in the middle of a massive surge (including on cruise ships!).
Nine areas of data we need to manage the pandemic
Will we ever get control of this pandemic? We can, but better data will go a long way in helping us get there. Here are nine areas where I'd like to see improvement.

Leave a Reply